Gastric cancer (GC) often develops resistance to cisplatin treatment, but while latent transforming growth factor β-binding protein (LTBP2) is recognized as a potential regulator in GC, its specific ...
At the 2025 Annual Congress of the European Association for Cancer Research (EACR), researchers from Cardiff University and collaborators presented their research on the role of BCL3 in tumor ...
New funding will help Cardiff University researchers further potential treatments for prostate cancer, through the first drug to target the BLC3 cell signalling pathway. Prostate Cancer UK have ...
The mammalian NF-κB p52:p52 homodimer together with its cofactor Bcl3 activates transcription of κB sites with a central G/C base pair (bp), while it is inactive toward κB sites with a central A/T bp.
Abstract: In present work chemical model describing mechanism of GaN etching and mechanism of Ga-rich layer formation in process of BCl 3 plasma treatment of GaN surface is proposed and included to ...
The NF-κB family of dimeric transcription factors regulate diverse biological functions. Their cellular expression profiles differ, which lead to different concentrations in different cell/tissue ...
With the market’s increasing demand for efficiency and quality, monocrystalline N-type cells have over recent years become a hot technology for the industrialization of high-efficiency cells, due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results